Notice: Undefined index: file in /nas/content/live/imagionbx/wp-includes/media.php on line 1658

Imagion Biosystems at BIO 2017

The 2017 International Convention of BIO, the Biotechnology Innovation Organization, was held June 19-22 in San Diego. More than 16,000 individuals attended…


Tumor Detection Study Presented at "Frontiers in Biomagnetic Particles" Conference

On June 5, 2017, Imagion Biosystems Chief Scientist Erika Vreeland, PhD, presented the results of a collaborative tumor detection study to the scientific…


Hear Bob Proulx Interviewed by Health Professional Radio

Imagion Biosystems President and CEO Bob Proulx was interviewed today by Health Professional Radio, a media network dedicated to promoting awareness on…


HER-2 Positive Tumor Detection at Tech Connect World Innovation Conference

This year's Tech Connect World Innovation Conference featured the poster "Superparamagnetic relaxometry (SPMR) for sensitive detection of HER-2 positive tumors…


Magnetic Relaxometry at the 2017 AACR Meeting

This year's Annual Meeting of the American Association for Cancer Research was held April 1-5 in Washington, D.C. The theme of this year's meeting was…


Magnetic Relaxometry at AACR 2017

This year's Annual Meeting of the American Association for Cancer Research was held April 1-5 in Washington, D.C. The theme of this year's meeting was…


Improving Detection Sensitivity

Scientists at Imagion Biosystems, along with our collaborators, continue to push back the boundaries of detection limits in our quest to improve on the early…


Detecting Small Tumors

Cancerous tumors start small and grow larger over time, adding defensive mechanisms that make them resistant to treatments and more deadly. So, to find cancers…


Earlier Detection Means An Earlier Cure

Data from the US National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program, charted below, illustrates the critical importance of…


Detecting Cancer Cells with Stealthy Nanoparticles

For effective use in detecting specific types of cancer, tumor-targeting nanoparticles must evade the immune system, remain intact for a clinically relevant…